P

Inventor

SASS PHILIP M

US58 patents
⚠️ This page may combine multiple inventors who share the name “SASS PHILIP M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MORPHOTEK INC

26 patents
US7592426B2Sep 22, 2009

Anti-mesothelin antibodies

MORPHOTEK INC38 citations96
US7615372B2Nov 10, 2009

Antibodies with immune effector activity and that internalize in endosialin-positive cells

MORPHOTEK INC12 citations93
US6808894B1Oct 26, 2004

Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics

MORPHOTEK INC43 citations93
US9115197B2Aug 25, 2015

Anti-mesothelin antibodies

MORPHOTEK INC15 citations92
US7741450B2Jun 22, 2010

Antibodies to GM-CSF

MORPHOTEK INC21 citations92
US9650440B2May 16, 2017

Monoclonal antibodies that specifically block biological activity of a tumor antigen

MORPHOTEK INC5 citations84
US8524237B2Sep 3, 2013

Antibodies with immune effector activity and that internalize in endosialin-positive cells

MORPHOTEK INC6 citations84
US6576468B1Jun 10, 2003

Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells

MORPHOTEK INC14 citations84
US9359428B2Jun 7, 2016

High affinity antibodies that neutralize Staphylococcus enterotoxin B

MORPHOTEK INC4 citations83
US8895704B2Nov 25, 2014

High affinity antibodies that neutralize Staphylococcus enterotoxin B

MORPHOTEK INC6 citations83
US7807382B2Oct 5, 2010

Methods for inhibiting the binding of endosialin to ligands

MORPHOTEK INC11 citations83
US7235643B2Jun 26, 2007

Antibodies and methods for generating genetically altered antibodies with high affinity

MORPHOTEK INC7 citations74
US6737268B1May 18, 2004

Method for generating genetically altered antigens

MORPHOTEK INC10 citations74
US9868780B2Jan 16, 2018

High affinity antibodies that neutralize Staphylococcus enterotoxin B

MORPHOTEK INC2 citations72
US9522195B2Dec 20, 2016

Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells

MORPHOTEK INC1 citations63
US7671179B2Mar 2, 2010

Antibodies and methods for generating genetically altered antibodies with high affinity

MORPHOTEK INC3 citations63
US7604994B2Oct 20, 2009

Genetically altered antibody-producing cell lines with improved antibody characteristics

MORPHOTEK INC5 citations63
US7332584B2Feb 19, 2008

Antibodies that specifically bind PMS2

MORPHOTEK INC3 citations63
US7223598B2May 29, 2007

Methods for isolating novel antimicrobial agents from hypermutable mammalian cells

MORPHOTEK INC2 citations63
US6982169B2Jan 3, 2006

Chemical inhibitors of mismatch repair

MORPHOTEK INC4 citations63
US9505842B2Nov 29, 2016

Methods for inhibiting the binding of endosialin to ligands

MORPHOTEK INC1 citations62
US8658173B2Feb 25, 2014

Anti-mesothelin antibodies

MORPHOTEK INC1 citations62
US7638334B2Dec 29, 2009

Method for generating engineered cells by homologously recombining segments having increased degeneracy

MORPHOTEK INC3 citations61
US7754450B2Jul 13, 2010

Methods of generating high-production of antibodies from hybridomas created by in vitro immunization

MORPHOTEK INC5 citations60
US10253106B2Apr 9, 2019

Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells

MORPHOTEK INC0 citations52
US8956832B2Feb 17, 2015

Cells expressing anti-GD2 antibodies and methods related thereto

MORPHOTEK INC0 citations52

UNIV JOHNS HOPKINS

7 patents

NICOLAIDES NICHOLAS C

5 patents

SASS PHILIP M

4 patents

EBEL WOLFGANG

2 patents

GRASSO LUIGI

2 patents

MORPHOTEK

1 patent

UNIV JOHNS HOPKINS MED

1 patent

ZHOU YUHONG

1 patent

EISAI INC

1 patent

Showing the top 50 of 58 patents by PatentIndex Score.